Proceedings of two satellite symposia held at EuroPCR, Paris in May 2015
Although the latest polymeric drug-eluting stents (DES) have enhanced percutaneous coronary intervention (PCI) procedures, a substantial proportion of patients requiring percutaneous transluminal coronary angiography (PTCA) is elderly with numerous different comorbidities. This population requires use of effective DES that can minimise the risk of bleeding and/or thrombosis. Two symposia were held at EuroPCR, the official congress of the European Association of Percutaneous Cardiovascular Interventions, in Paris on 19–22 May 2015, with the objectives of sharing clinical experiences in the use of absorbable polymer stents and to understand why an absorbable polymer DES may be specifically indicated in PCI subsets such as chronic total occlusions (CTOs) or tortuous coronary anatomies. To meet these clinical challenges, a novel DES was discussed: Coracto™ (Alvimedica) is a DES with a unique design that elutes sirolimus from an absorbable poly(lactic-co-glycolic acid) (PLGA) polymer.
The publication of this article was supported by Alvimedica.